• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and nursing is a difficult decision for women suffering from the condition. Little data exists about how long-term exposure to these medications may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus don't develop neurological disorders like hearing or vision impairment, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications must weigh the advantages of using them against the risks to the foetus. Physicians don't have the data to make unambiguous recommendations, but can provide information on the risks and benefits to assist pregnant women to make an informed decision.

A study published in Molecular Psychiatry found that women who used ADHD medications during early pregnancy did not have an increased risk of fetal heart malformations or major birth defects that are structural. Researchers conducted a massive sample-based case control study to assess the frequency of structural defects that were major in infants born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to make sure that the classification was correct and to minimize any bias.

The study conducted by the researchers was not without its limitations. The most important issue was that they were not able to differentiate the effects of the medication from the effects of the underlying disorder. That limitation makes it difficult to determine whether the small associations observed in the exposed groups are due to the use of medication or confounding by comorbidities. The researchers also did not study long-term outcomes for offspring.

The study revealed that infants whose mother took ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU) in comparison to mothers who did not take any medication during pregnancy or discontinued taking their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not affected by the stimulant medications used during pregnancy.

Women who used stimulant ADHD medication during pregnancy were also at an increased chance of having a caesarean section or having a baby with low Apgar score (less than 7). These increases did appear to be unrelated to the type of medication taken during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medications in early pregnancies could be offset by the greater benefits to both mother and baby of continuing treatment for the woman's condition. Physicians should speak with their patients about this and, if possible, help them develop coping strategies that can lessen the effects of her disorder on her daily life and relationships.

Medication Interactions

Many doctors are confronted with the dilemma of whether to keep treatment or stop it during pregnancy as more women are diagnosed with mild adhd medication. These decisions are usually taken without clear and authoritative evidence. Instead, doctors have to take into account their own experience, the experience of other doctors, and the research on the subject.

The issue of potential risks to infants is extremely difficult. Many studies on this topic are based on observational evidence rather than controlled research and their findings are often contradictory. The majority of studies limit their analysis to live-births, which could underestimate the severity of teratogenic effects leading to abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these shortcomings by looking at data from both live and deceased births.

Conclusion: While some studies have revealed an association between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. The majority of studies show that there is a neutral, or somewhat negative, impact. In all cases an in-depth study of the risks and benefits is required.

For many women with ADHD and ADD, the decision to discontinue medication can be difficult, if not impossible. In a recent article in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness and family conflict for these patients. A decrease in medication could also impact the ability to drive safely and perform work-related tasks, which are crucial aspects of everyday life for those with ADHD.

She suggests that women who are unsure about whether to keep or discontinue medication due to their pregnancy should consider the possibility of educating friends, family members and colleagues about the condition, its effects on daily functioning, and the benefits of keeping the current treatment plan. In addition, educating them can make the woman feel more comfortable as she struggles with her decision. It is also worth noting that some drugs can pass through the placenta, therefore, if a patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the medication could be transferred to the child.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns over the impact that these medications could have on fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing information on this topic. Utilizing two huge data sets researchers were able to examine more than 4.3 million pregnancies to determine whether stimulant medication use increased the risk of birth defects. Researchers discovered that, while the overall risk is low, the first trimester ADHD medication exposure was associated with slightly higher rates types Of adhd medication certain heart defects, like ventriculoseptal defect.

The authors of the study found no association between early use of medication and other congenital abnormalities, such as facial clefting or club foot. The results are in agreement with previous studies that showed the existence of a slight, but significant increase in the number of cardiac malformations among women who started taking adhd otc medication medication before the birth of their child. This risk increased during the latter part of pregnancy when many women began to stop taking their medication.

Women who took ADHD medications during the first trimester of their pregnancy were also more likely to have a caesarean section, a low Apgar score following delivery, and a baby that required breathing assistance during birth. However, the authors of the study were not able to eliminate bias due to selection by restricting the study to women who didn't have other medical issues that could have contributed to the findings.

Researchers hope their research will inform physicians when they meet pregnant women. The researchers suggest that, while discussing risks and benefits are important, the decision regarding whether or not to stop medication should be made in light of the severity of each woman's ADHD symptoms and her requirements.

The authors caution that, although stopping the medication is an option to look into, it is not advised due to the high rate depression and other mental disorders among women who are pregnant or have recently given birth. Further, the research suggests that women who choose to stop taking their medications are more likely to experience a difficult time adapting to life without them following the baby's arrival.

Nursing

It can be a stressful experience to become a mom. Women who suffer from ADHD are often faced with a number of difficulties when they must manage their symptoms, attend doctor appointments and prepare for the birth of a child and adjust to a new routine. As such, many women decide to continue taking their ADHD medications throughout pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medications passes through breast milk in low amounts. The rate of exposure to medication will vary based on the dosage the medication is administered, its frequency and time of day. In addition, different drugs enter the infant's system via the gastrointestinal tract or through breast milk. The impact on the health of a newborn isn't completely known.

Some doctors may stop taking stimulant medications during a woman's pregnancy due to the absence of research. This is a difficult choice for the patient, who must balance the benefits of continuing her medication against the potential dangers to the fetus. In the meantime, until more information is available, doctors should ask all pregnant patients about their experience with ADHD and if they are planning or taking to take medication during the perinatal period.

A increasing number of studies have shown that women can continue to take their ADHD medication during pregnancy and while breastfeeding. As a result, more and more patients choose to do so and, in consultation with their physician, they have discovered that the benefits of keeping their current medication outweigh any potential risks.

It is essential for women with ADHD who are considering breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should review their medications with their physician and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation is also needed to help pregnant women with ADHD be aware of the symptoms and underlying disorder. They should also learn about treatment options and build coping mechanisms. This should include a multidisciplinary approach with the GP, obstetricians and psychiatry. The pregnancy counselling should consist of discussion of a management plan for both mother and child, monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.